2006 February - 5 articles
The major breast cancer story of 2005 was trastuzumab, a monoclonal antibody directed against the Her-2 oncoprotein, and how it greatly improves outcomes for women with HER2-positive early-stage breast cancer. With early results showing that use of t...
An integrative approach for managing a patient with cancer should target the multiple biochemical and physiologic pathways that support tumour development and minimize normal-tissue toxicity. Angiogenesis is a key process in the promotion of cancer....
The Ottawa Rapid Palliative Radiotherapy Program (rprp) was established in 1999 with the goal of facilitating access by family physicians to radiotherapy services for patients with advanced symptomatic cancer. Two years later, an audit revealed that...
Since the early 1970s, a dramatic change has occurred in the epidemiology of esophageal malignancy in both North America and Europe: the incidence of adenocarcinomas of the lower esophagus and esophagogastric junction is increasing. Several lifestyle...
The HER2 gene (formerly called c-erbB-2) encodes a 185-kDa transmembrane glycoprotein with intracellular tyrosine kinase activity. [...]
Get Alerted
Add your email address to receive forthcoming issues of this journal.
